Loading...
Loading...
TELA| Name | Value |
|---|---|
| Revenues | 17.0M |
| Cost of Revenue | 5.4M |
| Gross Profit | 11.6M |
| Operating Expense | 23.9M |
| Operating I/L | -12.3M |
| Other Income/Expense | -0.6M |
| Interest Income | 0.0M |
| Pretax | -12.9M |
| Income Tax Expense | -4.7M |
| Net Income/Loss | -12.9M |
TELA Bio, Inc. is a medical technology company specializing in soft-tissue reconstruction solutions. The company's OviTex products, including Reinforced Tissue Matrix and PRS Reinforced Tissue Matrix, cater to hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. Additionally, TELA Bio offers OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber for use in laparoscopic and robotic-assisted hernia surgical repairs. TELA Bio generates revenue through the direct sales of its products, primarily in the United States.
